PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection
Status:
Completed
Trial end date:
2018-05-31
Target enrollment:
Participant gender:
Summary
This clinical trial studies positron emission tomography (PET)/computed tomography (CT) in
diagnosing patients with liver cancer undergoing surgical resection. Diagnostic procedures,
such as fluorine-18 fluoromethylcholine PET/CT, may help find and diagnose liver cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Queen's Medical Centre
Collaborators:
National Cancer Institute (NCI) National Institutes of Health (NIH) University of Hawaii Cancer Research Center